Holen Sie sich die Stockscreener-App
27.09
0.57%
-0.155
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
STAAR Surgical Announces Merger with Alcon Amid Legal Challenges - TradingView
Where Does STAAR Surgical Stand After EVO+ Launch and Recent Share Price Swings? - Yahoo
Large Staar Holders Oppose $1.5B Sale - Orange County Business Journal
Broadwood slams STAAR board over “carelessness” in Alcon sale defense By Investing.com - Investing.com Canada
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders - GlobeNewswire Inc.
Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus
Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale - TipRanks
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale - MarketScreener
Will STAAR Surgical Company benefit from macro trendsWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says - MSN
Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care Demand | DelveInsight - GlobeNewswire
Glass Lewis recommends against STAAR–Alcon merger, bolstering Broadwood’s campaign - Investing.com
Live market analysis of STAAR Surgical CompanyMarket Movers & Real-Time Chart Breakout Alerts - newser.com
STAAR Surgical (STAA): A Fresh Look at Valuation Following Recent Share Price Cooldown - simplywall.st
Glass Lewis Issues Recommendations to Shareholders of STAAR Surgical Company - MarketScreener
STAAR Surgical Board Defends $1.5 Billion Alcon Acquisition Plan - Finimize
AI Insurance Is Expensive - Bloomberg.com
Alcon (ALC) Faces Opposition in Staar Surgical Merger Deal - GuruFocus
STAAR urges shareholders to approve Alcon merger despite Glass Lewis report - Investing.com India
STAAR Surgical (STAA): Proxy Adviser Urges Rejection of Alcon De - GuruFocus
Glass Lewis Advises Against Alcon (ALC) Acquisition of STAAR - GuruFocus
STAAR Surgical Provides Information to Shareholders - MarketScreener
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon - MarketScreener
Defender Capital Opposes STAAR Surgical's Proposed Acquisition By Alcon - Nasdaq
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon - Yahoo Finance
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - Stocktwits
STAAR shareholders urged to vote for Alcon merger with 59% premium - Investing.com Canada
Yunqi Capital opposes sale of STAAR Surgical to Alcon - Investing.com
Yunqi Capital opposes sale of STAAR Surgical to Alcon By Investing.com - Investing.com Nigeria
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon - The Joplin Globe
$62/Share Offer Challenged: STAAR Shareholder Yunqi (5.1%) Reiterates Opposition Ahead of Vote - Stock Titan
STAAR Surgical Faces Shareholder Clash Over Alcon Buyout - Finimize
Broadwood urges STAAR shareholders to reject $28 per share Alcon deal - Investing.com
Broadwood urges shareholders to vote against proposed acquisition of STAAR by Alcon - MarketScreener
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon - Stock Titan
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims - MarketScreener
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis - Business Wire
59% premium to 90-day VWAP: STAAR Surgical backs $28 Alcon merger and urges stockholders to vote - Stock Titan
Major STAAR Surgical Investors Push Back On Alcon Acquisition - Finimize
STAAR Surgical (STAA): Evaluating Valuation Following Recent Share Price Surge - Yahoo
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - GlobeNewswire
Why STAAR Surgical Company stock could rally in 2025Earnings Recap Summary & Daily Entry Point Alerts - newser.com
27.5% Holder Broadwood Releases 81-Page Brief Urging STAAR Surgical Vote Against Alcon Deal - Stock Titan
How hedge fund analytics apply to STAAR Surgical Company stockWeekly Market Report & Safe Capital Preservation Plans - newser.com
Comparing STAAR Surgical Company in custom built stock radarsTrade Performance Summary & Comprehensive Market Scan Reports - newser.com
BUYOUT INVESTIGATION: Does $28.00 Per Share Buyout Offer Shortchange STAAR Surgical Company (NASDAQ: STAA) Shareholders? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm - PR Newswire
Combining price and volume data for STAAR Surgical CompanyTrade Analysis Report & Community Consensus Trade Alerts - newser.com
Alcon, STAAR Surgical see US antitrust waiting period expire - MLex
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR - MarketScreener
$1.5B Eye Care Merger Progresses: Alcon's Premium Buyout of STAAR Surgical Clears Key Regulatory Hurdle - Stock Titan
Broadwood files definitive proxy, STAAR reaffirms Alcon merger By Investing.com - Investing.com Nigeria
Broadwood files definitive proxy, STAAR reaffirms Alcon merger - Investing.com
Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance (NYSE:ALC) - Seeking Alpha
Yunqi Capital Ltd Increases Stake in Staar Surgical Co - GuruFocus
Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more (PFE:NYSE) - Seeking Alpha
0.94%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):